Data / Form D filings / Anteris Technologies Global Corp.
Anteris Technologies Global Corp.: Form D filing
Anteris Technologies Global Corp., a biotechnology company in Toowong, Qld, Australia, filed a Form D with the SEC in 2025. The latest, on November 7, 2025, reports $11.5 million sold of a $11.5 million offering to 9 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- Toowong Tower, Level 3, Suite 302, 9 Sherwood Road, Toowong, Qld, Australia, 4066
- Phone
- 61-7-3152-3200
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2024
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2011514
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 7, 2025 | New notice | $11,499,987 | $11,499,987 | 9 | Oct 23, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David Roberts | Director | |
| David St Denis | Director, Executive Officer | |
| Greg Moss | Director | |
| Stephen Denaro | Director | |
| Matthew McDonnell | Executive Officer | |
| Wayne Paterson | Director, Executive Officer | |
| John Seaberg | Director |
Every Form D from the week of Nov 3, 2025 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Anteris Technologies Global Corp. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.